Veeva Systems ROE 2012-2025 | VEEV
Current and historical return on equity (ROE) values for Veeva Systems (VEEV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Veeva Systems ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-04-30 | $0.78B | $6.21B | 13.74% |
| 2025-01-31 | $0.72B | $5.83B | 13.36% |
| 2024-10-31 | $0.67B | $5.50B | 13.18% |
| 2024-07-31 | $0.62B | $5.19B | 12.88% |
| 2024-04-30 | $0.56B | $4.89B | 12.31% |
| 2024-01-31 | $0.53B | $4.65B | 12.29% |
| 2023-10-31 | $0.57B | $4.38B | 14.03% |
| 2023-07-31 | $0.54B | $4.15B | 14.21% |
| 2023-04-30 | $0.52B | $3.94B | 14.52% |
| 2023-01-31 | $0.49B | $3.72B | 14.52% |
| 2022-10-31 | $0.40B | $3.42B | 12.53% |
| 2022-07-31 | $0.39B | $3.24B | 13.14% |
| 2022-04-30 | $0.41B | $3.07B | 14.50% |
| 2022-01-31 | $0.43B | $2.91B | 15.93% |
| 2021-10-31 | $0.43B | $2.77B | 17.19% |
| 2021-07-31 | $0.43B | $2.62B | 18.01% |
| 2021-04-30 | $0.41B | $2.45B | 18.69% |
| 2021-01-31 | $0.38B | $2.27B | 18.75% |
| 2020-10-31 | $0.34B | $2.11B | 18.27% |
| 2020-07-31 | $0.33B | $1.96B | 18.85% |
| 2020-04-30 | $0.31B | $1.80B | 19.41% |
| 2020-01-31 | $0.30B | $1.67B | 19.98% |
| 2019-10-31 | $0.31B | $1.56B | 21.88% |
| 2019-07-31 | $0.29B | $1.45B | 22.27% |
| 2019-04-30 | $0.26B | $1.34B | 21.68% |
| 2019-01-31 | $0.23B | $1.24B | 20.82% |
| 2018-10-31 | $0.20B | $1.14B | 19.57% |
| 2018-07-31 | $0.17B | $1.05B | 18.14% |
| 2018-04-30 | $0.16B | $0.97B | 18.35% |
| 2018-01-31 | $0.15B | $0.91B | 19.00% |
| 2017-10-31 | $0.14B | $0.82B | 19.14% |
| 2017-07-31 | $0.13B | $0.77B | 18.72% |
| 2017-04-30 | $0.10B | $0.71B | 16.11% |
| 2017-01-31 | $0.08B | $0.65B | 13.25% |
| 2016-10-31 | $0.07B | $0.61B | 11.96% |
| 2016-07-31 | $0.05B | $0.57B | 10.41% |
| 2016-04-30 | $0.05B | $0.53B | 11.00% |
| 2016-01-31 | $0.05B | $0.51B | 11.60% |
| 2015-10-31 | $0.05B | $0.47B | 11.11% |
| 2015-07-31 | $0.05B | $0.45B | 11.73% |
| 2015-04-30 | $0.05B | $0.43B | 11.69% |
| 2015-01-31 | $0.04B | $0.41B | 10.85% |
| 2014-10-31 | $0.02B | $0.38B | 7.12% |
| 2014-07-31 | $0.02B | $0.36B | 5.17% |
| 2014-04-30 | $0.01B | $0.33B | 5.45% |
| 2014-01-31 | $0.01B | $0.28B | 7.26% |
| 2013-07-31 | $0.02B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $45.858B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Doximity (DOCS) | United States | $11.546B | 53.45 |
| Hims & Hers Health (HIMS) | United States | $10.959B | 113.86 |
| Tempus AI (TEM) | United States | $10.129B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.936B | 61.50 |
| Hinge Health (HNGE) | United States | $3.363B | 0.00 |
| Privia Health (PRVA) | United States | $2.624B | 179.33 |
| Enovis (ENOV) | United States | $1.984B | 11.06 |
| Phreesia (PHR) | United States | $1.691B | 0.00 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.552B | 0.00 |
| Azenta (AZTA) | United States | $1.534B | 71.30 |
| 10x Genomics (TXG) | United States | $1.508B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 24.51 |
| Evolent Health (EVH) | United States | $1.383B | 117.80 |
| Claritev (CTEV) | United States | $0.815B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.594B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.477B | 0.00 |
| Talkspace (TALK) | United States | $0.457B | 136.50 |
| Veradigm (MDRX) | United States | $0.456B | 0.00 |
| Outset Medical (OM) | United States | $0.370B | 0.00 |
| TruBridge (TBRG) | United States | $0.345B | 766.33 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.272B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| American Well (AMWL) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.90 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.081B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.074B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.045B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |